Adrenal Hyperplasia, Congenital
Welcome,         Profile    Billing    Logout  
 8 Companies   9 Products   9 Products   7 Mechanisms of Action   0 Trials   60 News 


12»
  • ||||||||||  hydrocortisone / Generic mfg.
    Enrollment change, Trial completion date, Trial withdrawal, Trial primary completion date:  Effect of Short Term Adrenal Suppression on Androgen Overproduction in Overweight Girls With Androgen Excess (clinicaltrials.gov) -  Jul 19, 2018   
    P1,  N=0, Withdrawn, 
    Active, not recruiting --> Completed | Trial completion date: Dec 2022 --> Mar 2019 N=20 --> 0 | Trial completion date: Jun 2019 --> Jul 2018 | Not yet recruiting --> Withdrawn | Trial primary completion date: Jun 2019 --> Jul 2018
  • ||||||||||  leuprolide acetate for depot suspension / Generic mfg.
    Enrollment change, Trial completion date, Trial withdrawal, Trial primary completion date:  Effect of Short Term Ovarian Suppression on Androgen Overproduction in Overweight Girls With Androgen Excess (clinicaltrials.gov) -  Jul 19, 2018   
    P1,  N=0, Withdrawn, 
    N=20 --> 0 | Trial completion date: Jun 2019 --> Jul 2018 | Not yet recruiting --> Withdrawn | Trial primary completion date: Jun 2019 --> Jul 2018 N=20 --> 0 | Trial completion date: Jun 2020 --> Jul 2018 | Not yet recruiting --> Withdrawn | Trial primary completion date: Jun 2019 --> Jul 2018
  • ||||||||||  Trial completion, Enrollment change:  Decision Support for Parents Receiving Information About Child's Rare Disease (clinicaltrials.gov) -  Feb 20, 2018   
    P=N/A,  N=63, Completed, 
    N=20 --> 0 | Trial completion date: Jun 2020 --> Jul 2018 | Not yet recruiting --> Withdrawn | Trial primary completion date: Jun 2019 --> Jul 2018 Active, not recruiting --> Completed | N=45 --> 63
  • ||||||||||  leuprolide acetate for depot suspension / Generic mfg.
    Phase classification, Trial initiation date, Trial primary completion date:  Effect of Short Term Ovarian Suppression on Androgen Overproduction in Overweight Girls With Androgen Excess (clinicaltrials.gov) -  Jan 23, 2018   
    P1,  N=20, Not yet recruiting, 
    Phase classification: P=N/A --> P1 | Initiation date: Apr 2017 --> Apr 2018 | Trial primary completion date: Jun 2018 --> Jun 2019 Phase classification: P=N/A --> P1 | Initiation date: Jun 2017 --> Jun 2018 | Trial primary completion date: Jun 2018 --> Jun 2019
  • ||||||||||  Trial completion, Enrollment change, Trial primary completion date:  T2T@PSU: Tweens to Teens Project at Penn State (clinicaltrials.gov) -  Jan 8, 2018   
    P=N/A,  N=188, Completed, 
    Phase classification: P=N/A --> P1 | Initiation date: Jun 2017 --> Jun 2018 | Trial primary completion date: Jun 2018 --> Jun 2019 Recruiting --> Completed | N=300 --> 188 | Trial primary completion date: Jul 2011 --> Jul 2013
  • ||||||||||  Solu-Cortef (hydrocortisone sodium succinate injection) / Pfizer
    Trial completion, Trial primary completion date:  Comparison of Cortisol Pump With Standard Treatment for Congenital Adrenal Hyperplasia (clinicaltrials.gov) -  Dec 6, 2016   
    P2,  N=8, Completed, 
    N=53 --> 64 Active, not recruiting --> Completed | Trial primary completion date: Jun 2017 --> Dec 2016
  • ||||||||||  Solu-Cortef (hydrocortisone sodium succinate injection) / Pfizer
    Phase classification:  Comparison of Cortisol Pump With Standard Treatment for Congenital Adrenal Hyperplasia (clinicaltrials.gov) -  Apr 21, 2016   
    P2,  N=8, Active, not recruiting, 
    Recruiting --> Completed | Trial primary completion date: Feb 2016 --> Sep 2015 Phase classification: P1/2 --> P2
  • ||||||||||  Enrollment closed, Trial primary completion date:  11C-Metomidate PET Versus Adrenal Vein Sampling in Primary Aldosteronism (clinicaltrials.gov) -  Aug 19, 2015   
    P=N/A,  N=40, Active, not recruiting, 
    Active, not recruiting --> Completed Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2014 --> Aug 2015
  • ||||||||||  Solu-Cortef (hydrocortisone sodium succinate injection) / Pfizer
    Trial primary completion date:  Comparison of Cortisol Pump With Standard Treatment for Congenital Adrenal Hyperplasia (clinicaltrials.gov) -  Mar 11, 2015   
    P1/2,  N=8, Recruiting, 
    Active, not recruiting --> Completed | N=75 --> 53 Trial primary completion date: Dec 2016 --> Jun 2017
  • ||||||||||  Enrollment open, Trial primary completion date:  Decision Support for Parents Receiving Information About Child's Rare Disease (clinicaltrials.gov) -  Jul 12, 2014   
    P=N/A,  N=45, Recruiting, 
    Recruiting --> Active, not recruiting | Trial primary completion date: Jul 2015 --> Feb 2015 Not yet recruiting --> Recruiting | Trial primary completion date: Jul 2016 --> Mar 2016
  • ||||||||||  Enrollment change:  Obesity and Clinical Presentation of Hyperandrogenism (clinicaltrials.gov) -  Nov 3, 2013   
    P=N/A,  N=46, Completed, 
    Recruiting --> Active, not recruiting N=100 --> 46